Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2014

Open Access 01-12-2014 | Research article

Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF)

Authors: Noriyuki Enomoto, Hideki Kusagaya, Yoshiyuki Oyama, Masato Kono, Yusuke Kaida, Shigeki Kuroishi, Dai Hashimoto, Tomoyuki Fujisawa, Koshi Yokomura, Naoki Inui, Yutaro Nakamura, Takafumi Suda

Published in: BMC Pulmonary Medicine | Issue 1/2014

Login to get access

Abstract

Background

The pathological appearance of idiopathic pleuroparenchymal fibroelastosis (IPPFE) with hematoxylin-eosin staining is similar to that of usual interstitial pneumonia (UIP) in patients with idiopathic pulmonary fibrosis (IPF). The amount of elastic fibers (EF) and detailed differences between IPPFE and IPF have not been fully elucidated. The aim of this study was to quantify the EF and identify the differences between IPPFE and IPF.

Methods

We evaluated six patients with IPPFE and 28 patients with IPF who underwent surgical lung biopsy or autopsy. The patients’ clinical history, physical findings, chest high-resolution computed tomography (HRCT) findings, and pathological features of lung specimens were retrospectively evaluated. The amounts of EF in lung specimens were quantified with Weigert’s staining using a camera with a charge-coupled device and analytic software in both groups.

Results

Fewer patients with IPPFE than IPF had fine crackles (50.0% vs. 96.4%, p = 0.012). Patients with IPPFE had a lower forced vital capacity (62.7 ± 10.9% vs. 88.6 ± 21.9% predicted, p = 0.009), higher consolidation scores on HRCT (1.7 ± 0.8 vs. 0.3 ± 0.5, p < 0.0001), lower body mass indices (17.9 ± 0.9 vs. 24.3 ± 2.8, p < 0.0001), and more pneumothoraces than did patients with IPF (66.7 vs. 3.6%, p = 0.002). Lung specimens from patients with IPPFE had more than twice the amount of EF than did those from patients with IPF (28.5 ± 3.3% vs. 12.1 ± 4.4%, p < 0.0001). The amount of EF in the lower lobes was significantly lower than that in the upper lobes, even in the same patient with IPPFE (23.6 ± 2.4% vs. 32.4 ± 5.5%, p = 0.048). However, the amount of EF in the lower lobes of patients with IPPFE was still higher than that of patients with IPF (23.6 ± 2.4% vs. 12.2 ± 4.4%, p < 0.0001).

Conclusion

More than twice the amount of EF was found in patients with IPPFE than in those with IPF. Even in the lower lobes, the amount of EF was higher in patients with IPPFE than in those with IPF, although the distribution of lung EF was heterogeneous in IPPFE specimens.
Appendix
Available only for authorised users
Literature
1.
go back to reference Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, et al: An official american thoracic society/european respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013, 188 (6): 733-748. 10.1164/rccm.201308-1483ST.CrossRefPubMed Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, et al: An official american thoracic society/european respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013, 188 (6): 733-748. 10.1164/rccm.201308-1483ST.CrossRefPubMed
2.
go back to reference Frankel SK, Cool CD, Lynch DA, Brown KK: Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest. 2004, 126 (6): 2007-2013. 10.1378/chest.126.6.2007.CrossRefPubMed Frankel SK, Cool CD, Lynch DA, Brown KK: Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest. 2004, 126 (6): 2007-2013. 10.1378/chest.126.6.2007.CrossRefPubMed
3.
go back to reference Amitani R, Kuse F: Idiopathic pulmonary upper lobe fibrosis (IPUF). Kokyu. 1992, 11: 693-699. Amitani R, Kuse F: Idiopathic pulmonary upper lobe fibrosis (IPUF). Kokyu. 1992, 11: 693-699.
4.
go back to reference Kusagaya H, Nakamura Y, Kono M, Kaida Y, Kuroishi S, Enomoto N, Fujisawa T, Koshimizu N, Yokomura K, Inui N, Suda T, Colby TV, Chida K: Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients. BMC Pulm Med. 2012, 12: 72-10.1186/1471-2466-12-72.CrossRefPubMedPubMedCentral Kusagaya H, Nakamura Y, Kono M, Kaida Y, Kuroishi S, Enomoto N, Fujisawa T, Koshimizu N, Yokomura K, Inui N, Suda T, Colby TV, Chida K: Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients. BMC Pulm Med. 2012, 12: 72-10.1186/1471-2466-12-72.CrossRefPubMedPubMedCentral
5.
go back to reference Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, et al: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011, 183 (6): 788-824. 10.1164/rccm.2009-040GL.CrossRefPubMed Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, et al: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011, 183 (6): 788-824. 10.1164/rccm.2009-040GL.CrossRefPubMed
6.
go back to reference Reddy TL, Tominaga M, Hansell DM, von der Thusen J, Rassl D, Parfrey H, Guy S, Twentyman O, Rice A, Maher TM, Renzoni EA, Wells AU, Nicholson AG: Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J. 2012, 40 (2): 377-385. 10.1183/09031936.00165111.CrossRefPubMed Reddy TL, Tominaga M, Hansell DM, von der Thusen J, Rassl D, Parfrey H, Guy S, Twentyman O, Rice A, Maher TM, Renzoni EA, Wells AU, Nicholson AG: Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J. 2012, 40 (2): 377-385. 10.1183/09031936.00165111.CrossRefPubMed
7.
go back to reference Becker CD, Gil J, Padilla ML: Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity?. Mod Pathol. 2008, 21 (6): 784-787. 10.1038/modpathol.2008.56.CrossRefPubMed Becker CD, Gil J, Padilla ML: Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity?. Mod Pathol. 2008, 21 (6): 784-787. 10.1038/modpathol.2008.56.CrossRefPubMed
8.
go back to reference Enomoto N, Suda T, Kono M, Kaida Y, Hashimoto D, Fujisawa T, Inui N, Nakamura Y, Imokawa S, Funai K, Chida K: Amount of elastic fibers predicts prognosis of idiopathic pulmonary fibrosis. Respir Med. 2013, 107 (10): 1608-1616. 10.1016/j.rmed.2013.08.008.CrossRefPubMed Enomoto N, Suda T, Kono M, Kaida Y, Hashimoto D, Fujisawa T, Inui N, Nakamura Y, Imokawa S, Funai K, Chida K: Amount of elastic fibers predicts prognosis of idiopathic pulmonary fibrosis. Respir Med. 2013, 107 (10): 1608-1616. 10.1016/j.rmed.2013.08.008.CrossRefPubMed
9.
go back to reference Katzenstein AL, Myers JL: Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998, 157 (4 Pt 1): 1301-1315.CrossRefPubMed Katzenstein AL, Myers JL: Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998, 157 (4 Pt 1): 1301-1315.CrossRefPubMed
10.
go back to reference Piciucchi S, Tomassetti S, Casoni G, Sverzellati N, Carloni A, Dubini A, Gavelli G, Cavazza A, Chilosi M, Poletti V: High resolution CT and histological findings in idiopathic pleuroparenchymal fibroelastosis: features and differential diagnosis. Respir Res. 2011, 12: 111-10.1186/1465-9921-12-111.CrossRefPubMedPubMedCentral Piciucchi S, Tomassetti S, Casoni G, Sverzellati N, Carloni A, Dubini A, Gavelli G, Cavazza A, Chilosi M, Poletti V: High resolution CT and histological findings in idiopathic pleuroparenchymal fibroelastosis: features and differential diagnosis. Respir Res. 2011, 12: 111-10.1186/1465-9921-12-111.CrossRefPubMedPubMedCentral
11.
go back to reference Watanabe K, Nagata N, Kitasato Y, Wakamatsu K, Nabeshima K, Harada T, Hirota T, Shiraishi M, Fujita M: Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis. Respir Investig. 2012, 50 (3): 88-97. 10.1016/j.resinv.2012.06.003.CrossRefPubMed Watanabe K, Nagata N, Kitasato Y, Wakamatsu K, Nabeshima K, Harada T, Hirota T, Shiraishi M, Fujita M: Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis. Respir Investig. 2012, 50 (3): 88-97. 10.1016/j.resinv.2012.06.003.CrossRefPubMed
12.
go back to reference Rozin GF, Gomes MM, Parra ER, Kairalla RA, de Carvalho CR, Capelozzi VL: Collagen and elastic system in the remodelling process of major types of idiopathic interstitial pneumonias (IIP). Histopathology. 2005, 46 (4): 413-421. 10.1111/j.1365-2559.2005.02103.x.CrossRefPubMed Rozin GF, Gomes MM, Parra ER, Kairalla RA, de Carvalho CR, Capelozzi VL: Collagen and elastic system in the remodelling process of major types of idiopathic interstitial pneumonias (IIP). Histopathology. 2005, 46 (4): 413-421. 10.1111/j.1365-2559.2005.02103.x.CrossRefPubMed
13.
go back to reference Felicio CH, Parra ER, Capelozzi VL: Idiopathic and collagen vascular disease nonspecific interstitial pneumonia: clinical significance of remodeling process. Lung. 2007, 185 (1): 39-46. 10.1007/s00408-006-0104-2.CrossRefPubMed Felicio CH, Parra ER, Capelozzi VL: Idiopathic and collagen vascular disease nonspecific interstitial pneumonia: clinical significance of remodeling process. Lung. 2007, 185 (1): 39-46. 10.1007/s00408-006-0104-2.CrossRefPubMed
14.
go back to reference Raghow R, Lurie S, Seyer JM, Kang AH: Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis. J Clin Invest. 1985, 76 (5): 1733-1739. 10.1172/JCI112163.CrossRefPubMedPubMedCentral Raghow R, Lurie S, Seyer JM, Kang AH: Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis. J Clin Invest. 1985, 76 (5): 1733-1739. 10.1172/JCI112163.CrossRefPubMedPubMedCentral
15.
go back to reference Enomoto N, Suda T, Kato M, Kaida Y, Nakamura Y, Imokawa S, Ida M, Chida K: Quantitative analysis of fibroblastic foci in usual interstitial pneumonia. Chest. 2006, 130 (1): 22-29. 10.1378/chest.130.1.22.CrossRefPubMed Enomoto N, Suda T, Kato M, Kaida Y, Nakamura Y, Imokawa S, Ida M, Chida K: Quantitative analysis of fibroblastic foci in usual interstitial pneumonia. Chest. 2006, 130 (1): 22-29. 10.1378/chest.130.1.22.CrossRefPubMed
16.
go back to reference Kononov S, Brewer K, Sakai H, Cavalcante FS, Sabayanagam CR, Ingenito EP, Suki B: Roles of mechanical forces and collagen failure in the development of elastase-induced emphysema. Am J Respir Crit Care Med. 2001, 164 (10 Pt 1): 1920-1926.CrossRefPubMed Kononov S, Brewer K, Sakai H, Cavalcante FS, Sabayanagam CR, Ingenito EP, Suki B: Roles of mechanical forces and collagen failure in the development of elastase-induced emphysema. Am J Respir Crit Care Med. 2001, 164 (10 Pt 1): 1920-1926.CrossRefPubMed
17.
go back to reference Hirota T, Fujita M, Matsumoto T, Higuchi T, Shiraishi T, Minami M, Okumura M, Nabeshima K, Watanabe K: Pleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection?. Eur Respir J. 2013, 41 (1): 243-245. 10.1183/09031936.00103912.CrossRefPubMed Hirota T, Fujita M, Matsumoto T, Higuchi T, Shiraishi T, Minami M, Okumura M, Nabeshima K, Watanabe K: Pleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection?. Eur Respir J. 2013, 41 (1): 243-245. 10.1183/09031936.00103912.CrossRefPubMed
18.
go back to reference Hardie WD, Piljan-Gentle A, Dunlavy MR, Ikegami M, Korfhagen TR: Dose-dependent lung remodeling in transgenic mice expressing transforming growth factor-alpha. Am J Physiol Lung Cell Mol Physiol. 2001, 281 (5): L1088-L1094.PubMed Hardie WD, Piljan-Gentle A, Dunlavy MR, Ikegami M, Korfhagen TR: Dose-dependent lung remodeling in transgenic mice expressing transforming growth factor-alpha. Am J Physiol Lung Cell Mol Physiol. 2001, 281 (5): L1088-L1094.PubMed
19.
go back to reference Hardie WD, Le Cras TD, Jiang K, Tichelaar JW, Azhar M, Korfhagen TR: Conditional expression of transforming growth factor-alpha in adult mouse lung causes pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2004, 286 (4): L741-L749.CrossRefPubMed Hardie WD, Le Cras TD, Jiang K, Tichelaar JW, Azhar M, Korfhagen TR: Conditional expression of transforming growth factor-alpha in adult mouse lung causes pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2004, 286 (4): L741-L749.CrossRefPubMed
20.
go back to reference Selman M, King TE, Pardo A: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001, 134 (2): 136-151. 10.7326/0003-4819-134-2-200101160-00015.CrossRefPubMed Selman M, King TE, Pardo A: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001, 134 (2): 136-151. 10.7326/0003-4819-134-2-200101160-00015.CrossRefPubMed
21.
go back to reference Coward WR, Saini G, Jenkins G: The pathogenesis of idiopathic pulmonary fibrosis. Ther Adv Respir Dis. 2010, 4 (6): 367-388. 10.1177/1753465810379801.CrossRefPubMed Coward WR, Saini G, Jenkins G: The pathogenesis of idiopathic pulmonary fibrosis. Ther Adv Respir Dis. 2010, 4 (6): 367-388. 10.1177/1753465810379801.CrossRefPubMed
22.
go back to reference Fuke S, Betsuyaku T, Oizumi S, Nasuhara Y, Saito H, Yamaguchi E, Nishimura M: A case of idiopathic pulmonary upper lobe fibrosis complicated by invasive pulmonary aspergillosis. Nihon Kokyuki Gakkai Zasshi. 2003, 41 (3): 196-201.PubMed Fuke S, Betsuyaku T, Oizumi S, Nasuhara Y, Saito H, Yamaguchi E, Nishimura M: A case of idiopathic pulmonary upper lobe fibrosis complicated by invasive pulmonary aspergillosis. Nihon Kokyuki Gakkai Zasshi. 2003, 41 (3): 196-201.PubMed
23.
go back to reference Nei T, Kawamoto M, Satoh E, Takaku T, Seo Y, Morimoto T, Hattori K, Saito Y, Abe S, Usuki J, Azuma A, Nakayama T, Fukuda Y, Kudoh S, Gemma A: A case of suspected idiopathic pulmonary upper lobe fibrosis (Amitani disease) with acute exacerbation. Nihon Kokyuki Gakkai Zasshi. 2009, 47 (2): 116-121.PubMed Nei T, Kawamoto M, Satoh E, Takaku T, Seo Y, Morimoto T, Hattori K, Saito Y, Abe S, Usuki J, Azuma A, Nakayama T, Fukuda Y, Kudoh S, Gemma A: A case of suspected idiopathic pulmonary upper lobe fibrosis (Amitani disease) with acute exacerbation. Nihon Kokyuki Gakkai Zasshi. 2009, 47 (2): 116-121.PubMed
24.
go back to reference Morimoto A, Mochizuki Y, Nakahara Y, Kawamura T, Sakaki S, Kobashi Y: Case of idiopathic pulmonary upper lobe fibrosis. Nihon Kokyuki Gakkai Zasshi. 2010, 48 (12): 944-949.PubMed Morimoto A, Mochizuki Y, Nakahara Y, Kawamura T, Sakaki S, Kobashi Y: Case of idiopathic pulmonary upper lobe fibrosis. Nihon Kokyuki Gakkai Zasshi. 2010, 48 (12): 944-949.PubMed
Metadata
Title
Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF)
Authors
Noriyuki Enomoto
Hideki Kusagaya
Yoshiyuki Oyama
Masato Kono
Yusuke Kaida
Shigeki Kuroishi
Dai Hashimoto
Tomoyuki Fujisawa
Koshi Yokomura
Naoki Inui
Yutaro Nakamura
Takafumi Suda
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2014
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-14-91

Other articles of this Issue 1/2014

BMC Pulmonary Medicine 1/2014 Go to the issue